eli lilly and company tirzepatide Lilly's slashes risk of type 2 diabetes by 94% in Phase 3 trial Lilly releases Zepbound® (tirzepatide) single-dose

We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in Florida

Treat anything you cannot independently confirm as unverified

Dr Kwong recommends a protein-first approach to support muscle mass and energy, especially while appetite is reduced

Shifts in hormones, metabolism, and body composition can make this transition especially difficult for weight management